Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Fine control of Wnt signaling is essential for various cellular and developmental decision-making processes. However, deregulation of Wnt signaling leads to pathological consequences, one of which is cancer. Here, we identify a function of PAF, a component of translesion DNA synthesis, in modulating Wnt signaling. PAF is specifically overexpressed in colon cancer cells and intestinal stem cells and is required for colon cancer cell proliferation. In Xenopus laevis, ventrovegetal expression of PAF hyperactivates Wnt signaling, developing a secondary axis with β-catenin target gene upregulation. Upon Wnt signaling activation, PAF dissociates from PCNA and binds directly to β-catenin. Then, PAF recruits EZH2 to the β-catenin transcriptional complex and specifically enhances Wnt target gene transactivation, independently of EZH2's methyltransferase activity. In mice, conditional expression of PAF induces intestinal neoplasia via Wnt signaling hyperactivation. Our studies reveal an unexpected role of PAF in regulating Wnt signaling and propose a regulatory mechanism of Wnt signaling during tumorigenesis.
Ahn,
BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb.
2001, Pubmed
Ahn,
BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb.
2001,
Pubmed Amrani,
The Paf oncogene is essential for hematopoietic stem cell function and development.
2011,
Pubmed Barker,
Crypt stem cells as the cells-of-origin of intestinal cancer.
2009,
Pubmed Beachy,
Tissue repair and stem cell renewal in carcinogenesis.
2004,
Pubmed Carrera,
Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13.
2008,
Pubmed Chang,
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
2011,
Pubmed Cheng,
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
2011,
Pubmed Clevers,
Wnt/β-catenin signaling and disease.
2012,
Pubmed Deka,
Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
2010,
Pubmed Derks,
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
2009,
Pubmed Emanuele,
Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate.
2011,
Pubmed Funayama,
Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.
1995,
Pubmed
,
Xenbase Fussbroich,
EZH2 depletion blocks the proliferation of colon cancer cells.
2011,
Pubmed Goentoro,
Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling.
2009,
Pubmed
,
Xenbase He,
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
2005,
Pubmed He,
Identification of c-MYC as a target of the APC pathway.
1998,
Pubmed Imbert,
Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland.
2001,
Pubmed Jho,
Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
2002,
Pubmed Joshi,
Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.
2008,
Pubmed Jung,
Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.
2013,
Pubmed Kengaku,
Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud.
1998,
Pubmed Kim,
Mitogenic influence of human R-spondin1 on the intestinal epithelium.
2005,
Pubmed Kondo,
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
2008,
Pubmed Kuzmichev,
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
2005,
Pubmed Li,
Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.
2009,
Pubmed Lustig,
Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.
2002,
Pubmed Moser,
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.
1990,
Pubmed Park,
Telomerase modulates Wnt signalling by association with target gene chromatin.
2009,
Pubmed
,
Xenbase Polakis,
The many ways of Wnt in cancer.
2007,
Pubmed Povlsen,
Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
2012,
Pubmed Sage,
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
2003,
Pubmed Sale,
Y-family DNA polymerases and their role in tolerance of cellular DNA damage.
2012,
Pubmed Sangiorgi,
Bmi1 is expressed in vivo in intestinal stem cells.
2008,
Pubmed Schwab,
Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development.
2007,
Pubmed Shi,
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.
2007,
Pubmed Sparmann,
Polycomb silencers control cell fate, development and cancer.
2006,
Pubmed Suzuki,
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
2004,
Pubmed Tetsu,
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
1999,
Pubmed Vermeulen,
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
2010,
Pubmed Wyngaarden,
Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb.
2011,
Pubmed Xu,
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.
2012,
Pubmed Yu,
p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues.
2001,
Pubmed Zhang,
Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2.
2007,
Pubmed Zhang,
PAF makes it EZ(H2) for β-catenin transactivation.
2013,
Pubmed
